Psychedelics as Therapeutics-Potential and Challenges.
Nora D. Volkow, J. Gordon, Eric M. Wargo
JAMA Psychiatry July 26, 2023 DOI: 10.1001/jamapsychiatry.2023.1968 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Viewpoint Peer reviewed |
|---|---|
| Key points | Psychedelics show potential for treating mental illness and substance use disorders, though open research questions and unique challenges persist. |
Abstract
This Viewpoint discusses the potential promise of the therapeutic use of psychedelics for mental illness and substance use disorders, acknowledging many open research questions and unique challenges with these substances.
Citations in the library
Cited by 23
- Rethinking the role of TRKB in the action of antidepressants and psychedelics. Trends in Neurosciences November 1, 2024
- Psychedelics for the Treatment of Psychiatric Disorders: Interpreting and Translating Available Evidence and Guidance for Future Research. American Journal of Psychiatry 2025
- Practical considerations in the establishment of psychedelic research programs. Psychopharmacology 2025
- Developing the Open Psychedelic Evaluation Nexus consensus measures for assessment of supervised psilocybin services: An e-Delphi study Journal of Psychopharmacology June 18, 2024
- From Efficacy to Effectiveness: Evaluating Psychedelic Randomized Controlled Trials for Trustworthy Evidence‐Based Policy and Practice Pharmacology Research & Perspectives April 1, 2025
and 18 more in the library
Cites 8
- Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression. New England Journal of Medicine November 3, 2022
- The Subjective Effects of Psychedelics Are Necessary for Their Enduring Therapeutic Effects. ACS Pharmacology & Translational Science December 10, 2020
- Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors Science February 16, 2023
- Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice Proceedings of the National Academy of Sciences April 13, 2021
- The Subjective Effects of Psychedelics May Not Be Necessary for Their Enduring Therapeutic Effects ACS Pharmacology & Translational Science December 10, 2020
and 3 more in the library